1. Home
  2. DLPN vs ALLR Comparison

DLPN vs ALLR Comparison

Compare DLPN & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DLPN
  • ALLR
  • Stock Information
  • Founded
  • DLPN 1996
  • ALLR 2004
  • Country
  • DLPN United States
  • ALLR United States
  • Employees
  • DLPN N/A
  • ALLR N/A
  • Industry
  • DLPN Other Consumer Services
  • ALLR Biotechnology: Pharmaceutical Preparations
  • Sector
  • DLPN Consumer Discretionary
  • ALLR Health Care
  • Exchange
  • DLPN Nasdaq
  • ALLR Nasdaq
  • Market Cap
  • DLPN 21.8M
  • ALLR 20.2M
  • IPO Year
  • DLPN N/A
  • ALLR N/A
  • Fundamental
  • Price
  • DLPN $1.59
  • ALLR $1.23
  • Analyst Decision
  • DLPN Strong Buy
  • ALLR Strong Buy
  • Analyst Count
  • DLPN 1
  • ALLR 1
  • Target Price
  • DLPN $5.00
  • ALLR $9.25
  • AVG Volume (30 Days)
  • DLPN 42.7K
  • ALLR 262.6K
  • Earning Date
  • DLPN 11-12-2025
  • ALLR 11-14-2025
  • Dividend Yield
  • DLPN N/A
  • ALLR N/A
  • EPS Growth
  • DLPN N/A
  • ALLR N/A
  • EPS
  • DLPN N/A
  • ALLR N/A
  • Revenue
  • DLPN $51,257,243.00
  • ALLR N/A
  • Revenue This Year
  • DLPN $9.05
  • ALLR N/A
  • Revenue Next Year
  • DLPN $15.42
  • ALLR N/A
  • P/E Ratio
  • DLPN N/A
  • ALLR N/A
  • Revenue Growth
  • DLPN 4.84
  • ALLR N/A
  • 52 Week Low
  • DLPN $0.75
  • ALLR $0.61
  • 52 Week High
  • DLPN $1.88
  • ALLR $2.35
  • Technical
  • Relative Strength Index (RSI)
  • DLPN 49.69
  • ALLR 40.99
  • Support Level
  • DLPN $1.43
  • ALLR $1.09
  • Resistance Level
  • DLPN $1.79
  • ALLR $1.45
  • Average True Range (ATR)
  • DLPN 0.14
  • ALLR 0.09
  • MACD
  • DLPN -0.03
  • ALLR -0.02
  • Stochastic Oscillator
  • DLPN 29.78
  • ALLR 37.42

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

Share on Social Networks: